Skip to content
PaperFren

WeChat monitoring of home COVID patients

Open paper intelligence

WeChat-based telemedicine monitored 74 home-quarantined COVID-19 patients; 8% needed admission and all recovered.

Source

Monitoring and Management of Home-Quarantined Patients With COVID-19 Using a WeChat-Based Telemedicine System: Retrospective Cohort Study

Xu H, Huang S, Qiu C, et al. · Journal of medical Internet research · 2020

doi.org/10.2196/19514Read the full paper ↗83 citationscc by

Study at a glance

Design
Other — WeChat telemedicine monitoring programme for home-quarantined COVID-19 patients (not randomised)
N
N=74 · 6 (8%) hospitalised after detected deterioration; all 74 recovered
Population
Home-quarantined patients with COVID-19
Outcome
Detection of deterioration requiring hospital admission

Structured fields used in claim comparison tables when every cited study has a complete layer.

What they did

Investigators used a WeChat telemedicine system with structured symptom assessment to monitor home-quarantined COVID-19 patients and escalate care when deterioration was detected.

What they found

Among 74 patients, 6 (8%) were hospitalised after detected deterioration; all 74 recovered.

The limits

What it doesn't show

Small single-system retrospective series without a concurrent control group cannot prove telemedicine caused recovery.

Key terms

WeChat telemedicine
Messaging-app platform for remote COVID monitoring.
Home quarantine
Isolation and care at home for mild COVID.
Escalation
Hospital referral when deterioration detected.
Retrospective cohort
Outcomes described after care already delivered.
Symptom assessment
Structured indicators used to track status.
ECMO
Advanced life support mentioned for one severe case.

Flashcards

1 / 10

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 6

N monitored:

Common questions

N?

74.

Admitted?

6 (8%).

Recovered?

All 74.

Platform?

WeChat.

More on Telemedicine